BIOKIN PHARMACEUTICAL(SH:688506) Xin Lang Cai Jing·2025-10-26 07:08Core Viewpoint - This week, seven companies submitted listing applications to the Hong Kong Stock Exchange, with three companies passing the hearing, five companies conducting IPOs, and three new stocks being listed [1]. Group 1: Companies Submitting Listing Applications - Guangdong Jintian Animation Co., Ltd. submitted a listing application on October 20, focusing on the IP fun food industry with a projected revenue of approximately RMB 5.96 billion in 2022, growing to RMB 8.77 billion by 2024 [2]. - Yuwang Biological Nutrition Co., Ltd. is the largest supplier of food-grade refined fish oil globally, with a market share of 8.1% and projected revenues of RMB 5.34 billion in 2022, increasing to RMB 8.32 billion by 2024 [3]. - Binhua Group Co., Ltd. is a leader in the chlor-alkali chemical industry, with revenues of RMB 88.92 billion in 2022, expected to reach RMB 102.28 billion by 2024 [4]. - Xichang Zhihui Mining Co., Ltd. focuses on mining zinc, lead, and copper in Tibet, with revenues of RMB 4.82 billion in 2022, projected to decline to RMB 3.01 billion by 2024 [5]. - Zhongwei Co., Ltd. specializes in new energy battery materials, with total revenues of RMB 303.44 billion in 2022, expected to grow to RMB 402.23 billion by 2024 [6]. - Hehui Optoelectronics Co., Ltd. is a leading AMOLED semiconductor display panel manufacturer, with revenues of RMB 41.91 billion in 2022, projected to reach RMB 49.58 billion by 2024 [7]. Group 2: Companies Passing Hearing - Suzhou Wangshan Wangshui Biomedical Co., Ltd. focuses on small molecule drug development, with revenues of RMB 2 billion in 2022, declining to RMB 322.4 million by 2024 [8]. - Guangdong Tianyu Semiconductor Co., Ltd. is the largest silicon carbide epitaxial wafer manufacturer in China, with revenues of RMB 4.37 billion in 2022, expected to grow to RMB 11.71 billion by 2023 [9]. - Baile Tianheng is a biopharmaceutical company focusing on tumor treatment, with revenues of RMB 7.02 billion in 2022, projected to reach RMB 58.21 billion by 2024 [10]. Group 3: Companies Conducting IPOs - Sany Heavy Industry Co., Ltd. had an oversubscription of 53 times, raising approximately HKD 663 billion (USD 85 billion) [11]. - Dippu Technology Co., Ltd. had an oversubscription of 7590 times, raising HKD 2,721 billion, making it the second-highest oversubscription in history [12]. - Cambridge Technology Co., Ltd. set its final price at HKD 68.88 per share, with significant backing from cornerstone investors [13]. - Bama Tea Co., Ltd. attracted approximately 169,000 subscription applications, with an oversubscription of 2684 times [14]. - Minglue Technology Co., Ltd. plans to issue 721.9 million A shares, with a proposed price of HKD 141.00 per share [15]. Group 4: Newly Listed Stocks - Haixi New Drug Co., Ltd. saw a first-day increase of 20.60%, with a total increase of 26.74% in the first week [15]. - Jushuitan Co., Ltd. had a first-day increase of 23.86%, but saw a decline in the following days, ending the week with a 13.92% increase [16]. - Guanghe Tong Co., Ltd. experienced a first-day drop of 11.72%, with a total decline of 9.44% in the first week [17].